세계의 경피 패치 시장 - 시장 규모, 점유율, 산업 동향 분석 보고서 : 최종 사용자별, 유통 채널별, 점착제 유형별, 패치 유형별, 지역별 전망 및 예측(2023-2030년)

The Global Transdermal Patches Market size is expected to reach $8.5 billion by 2030, rising at a market growth of 5.1% CAGR during the forecast period. In the year 2022, the market attained a volume of 33,59,966.8 thousand units, experiencing a growth of 4.6% (2019-2022).

Cardiovascular diseases, including hypertension and angina, remain the leading causes of morbidity and mortality worldwide. Therefore, the cardiovascular disorder segment captured $413.3 million revenue in the market in 2022. The increasing prevalence of these disorders has driven the demand for innovative and efficient treatment options, positioning transdermal patches as a viable solution. Cardiovascular patients often require long-term medication to manage their conditions. These offer a convenient and patient-friendly alternative to oral medications, potentially improving patient adherence. These factors will pose lucrative growth prospects for the segment. Some of the factors impacting the market are improved patient convenience with these, growing aging population in various countries, and limited drug loading capacity.

Transdermal patches are easy to apply and can be administered by patients themselves without the need for healthcare professionals. This simplicity makes them an attractive option for individuals who prefer self-administration. Unlike oral medications or injections, these do not require water for administration or using needles. This makes them particularly convenient for patients who may have difficulty swallowing pills or who are averse to injections. In addition, these are non-invasive, eliminating the pain associated with injections and the discomfort of repeated needle use. Additionally, these are easy to apply, making them a user-friendly option for seniors with mobility or dexterity challenges. For individuals who may find it challenging to manage multiple medications with different dosing schedules, these offer a convenient way to administer drugs without the need for frequent manual dosing. Older adults may experience difficulty swallowing pills, a condition known as dysphagia. Transdermal patches eliminate the need for swallowing, providing an alternative for those who struggle with oral medication. These factors will help expand the market.

However, various patch sizes are available, and the quantity of medication that can be applied to one is limited by the surface area of the patch. Larger doses may require larger patches, and there are practical limits to how big a patch can be applied comfortably. The skin has limitations regarding the rate at which it can absorb drugs. If a patch delivers too much drug at once, it may exceed the skin's absorption capacity, leading to potential issues such as skin irritation or the inability to deliver the drug effectively. These aspects can hamper the growth of the market.

The global lockdowns, restrictions on movement, and disruptions in transportation during the early stages of the pandemic led to challenges in the supply chain for pharmaceutical products. This affected the production and distribution of transdermal patches, potentially causing delays in manufacturing and delivery. The focus of healthcare systems and professionals shifted significantly toward addressing the immediate challenges posed by the pandemic. The pandemic disrupted ongoing and planned clinical trials across various therapeutic areas. This interruption affected the development and regulatory approval of new transdermal patch products.

End User Outlook

On the basis of end user, the market is bifurcated into homecare settings and hospitals & clinics. In 2022, the homecare settings segment witnessed the maximum revenue share in the market. These offer a non-invasive and convenient method of drug delivery. Patients can easily apply the patches at home without the need for healthcare professionals, reducing the necessity for frequent visits to healthcare facilities. This convenience is particularly beneficial for individuals managing chronic conditions that require continuous medication. Therefore, the segment will witness a rise in demand in the coming years.

Distribution Channel Outlook

Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the retail pharmacies segment garnered a significant revenue share in the market. Many transdermal patches, especially those used for common conditions like pain relief or smoking cessation, are available over the counter. Retail pharmacies serve as key distribution points for OTC transdermal patches, allowing consumers to purchase without needing a doctor's prescription. These factors will propel the demand in the segment.

Adhesive Type Outlook

On the basis of adhesive type, the market is divided into acrylic adhesives, silicone adhesives, hydrogel adhesives, and others. The acrylic adhesives segment recorded the maximum revenue share in the market in 2022. Acrylic adhesives are known for their strong and durable adhesion properties. In the context of transdermal patches, which require prolonged adhesion to the skin for controlled drug delivery, the excellent bonding capabilities of acrylic adhesives contribute to the overall effectiveness of the patches. Many acrylic adhesives used in these are formulated to be skin-friendly.

Patch Type Outlook

Based on patch type, the market is segmented into drug-in-adhesive, matrix patches, reservoir membrane patches, microneedle patches, iontophoresis patches, and vapour patches. The reservoir membrane patches segment procured a promising growth rate in the market in 2022. The reservoir membrane design allows for a more controlled and precise release of drugs. It typically consists of a drug reservoir separated from the skin by a semipermeable membrane. This membrane controls the rate at which the drug is released, resulting in a more predictable and sustained release profile.

Application Outlook

Based on application, the market is divided into pain management, smoking cessation, hormone replacement therapy, cardiovascular disorder, central nervous system disorder, and others. The pain management segment recorded the maximum revenue share in the market in 2022. Chronic pain conditions, such as osteoarthritis, neuropathic pain, and musculoskeletal disorders, are prevalent worldwide. These offer a sustained and controlled release of analgesic medications, providing a valuable solution for patients managing long-term pain.

Regional Outlook

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America segment acquired the highest revenue share in the market. North America, including the United States and Canada, is characterized by a high prevalence of chronic diseases such as diabetes, cardiovascular disorders, and chronic pain conditions. Transdermal patches provide a convenient and effective means of delivering medications for long-term management of these conditions. The rising burden of chronic diseases has contributed to the growing demand in the region.

The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Acquisitions, and Partnerships & Collaborations.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Viatris, Inc. (Mylan N.V.), Boehringer Ingelheim International GmbH, Endo International PLC, Bayer AG, Nitto Denko Corporation, Cipla Limited, Amneal Pharmaceuticals, Inc., Novartis AG, and AbbVie, Inc.

Scope of the Study

Market Segments covered in the Report:

By End User (Volume, Thousand Units, USD Billion, 2019-2030)

• Homecare Settings
• Hospitals & Clinics

By Distribution Channel (Volume, Thousand Units, USD Billion, 2019-2030)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Adhesive Type (Volume, Thousand Units, USD Billion, 2019-2030)

• Acrylic Adhesives
• Silicone Adhesives
• Hydrogel Adhesives
• Others

By Patch Type (Volume, Thousand Units, USD Billion, 2019-2030)

• Drug-In-Adhesive
• Matrix Patches
• Reservoir Membrane Patches
• Microneedle Patches
• Iontophoresis Patches
• Vapour Patches

By Application (Volume, Thousand Units, USD Billion, 2019-2030)

• Pain Management
• Smoking Cessation
• Hormone Replacement Therapy
• Cardiovascular Disorder
• Central Nervous System Disorder
• Others

By Geography (Volume, Thousand Units, USD Billion, 2019-2030)

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Johnson & Johnson
• Viatris, Inc. (Mylan N.V.)
• Boehringer Ingelheim International GmbH
• Endo International PLC
• Bayer AG
• Nitto Denko Corporation
• Cipla Limited
• Amneal Pharmaceuticals, Inc.
• Novartis AG
• AbbVie, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Transdermal Patches Market, by End User
  • 1.4.2 Global Transdermal Patches Market, by Distribution Channel
  • 1.4.3 Global Transdermal Patches Market, by Adhesive Type
  • 1.4.4 Global Transdermal Patches Market, by Patch Type
  • 1.4.5 Global Transdermal Patches Market, by Application
  • 1.4.6 Global Transdermal Patches Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

• 4.1 Market Share Analysis, 2022
• 4.2 Porter's Five Forces Analysis

Chapter 5. Global Transdermal Patches Market by End User

• 5.1 Global Homecare Settings Market by Region
• 5.2 Global Hospitals & Clinics Market by Region

Chapter 6. Global Transdermal Patches Market by Distribution Channel

• 6.1 Global Hospital Pharmacies Market by Region
• 6.2 Global Retail Pharmacies Market by Region
• 6.3 Global Online Pharmacies Market by Region

Chapter 7. Global Transdermal Patches Market by Adhesive Type

• 7.1 Global Acrylic Adhesives Market by Region
• 7.2 Global Silicone Adhesives Market by Region
• 7.3 Global Hydrogel Adhesives Market by Region
• 7.4 Global Others Market by Region

Chapter 8. Global Transdermal Patches Market by Patch Type

• 8.1 Global Drug-In-Adhesive Market by Region
• 8.2 Global Matrix Patches Market by Region
• 8.3 Global Reservoir Membrane Patches Market by Region
• 8.4 Global Microneedle Patches Market by Region
• 8.5 Global Iontophoresis Patches Market by Region
• 8.6 Global Vapour Patches Market by Region

Chapter 9. Global Transdermal Patches Market by Application

• 9.1 Global Pain Management Market by Region
• 9.2 Global Smoking Cessation Market by Region
• 9.3 Global Hormone Replacement Therapy Market by Region
• 9.4 Global Cardiovascular Disorder Market by Region
• 9.5 Global Central Nervous System Disorder Market by Region
• 9.6 Global Others Market by Regio

Chapter 10. Global Transdermal Patches Market by Region

• 10.1 North America Transdermal Patches Market
  • 10.1.1 North America Transdermal Patches Market by End User
    • 10.1.1.1 North America Homecare Settings Market by Region
    • 10.1.1.2 North America Hospitals & Clinics Market by Region
  • 10.1.2 North America Transdermal Patches Market by Distribution Channel
    • 10.1.2.1 North America Hospital Pharmacies Market by Country
    • 10.1.2.2 North America Retail Pharmacies Market by Country
    • 10.1.2.3 North America Online Pharmacies Market by Country
  • 10.1.3 North America Transdermal Patches Market by Adhesive Type
    • 10.1.3.1 North America Acrylic Adhesives Market by Country
    • 10.1.3.2 North America Silicone Adhesives Market by Country
    • 10.1.3.3 North America Hydrogel Adhesives Market by Country
    • 10.1.3.4 North America Others Market by Country
  • 10.1.4 North America Transdermal Patches Market by Patch Type
    • 10.1.4.1 North America Drug-In-Adhesive Market by Country
    • 10.1.4.2 North America Matrix Patches Market by Country
    • 10.1.4.3 North America Reservoir Membrane Patches Market by Country
    • 10.1.4.4 North America Microneedle Patches Market by Country
    • 10.1.4.5 North America Iontophoresis Patches Market by Country
    • 10.1.4.6 North America Vapour Patches Market by Country
  • 10.1.5 North America Transdermal Patches Market by Application
    • 10.1.5.1 North America Pain Management Market by Country
    • 10.1.5.2 North America Smoking Cessation Market by Country
    • 10.1.5.3 North America Hormone Replacement Therapy Market by Country
    • 10.1.5.4 North America Cardiovascular Disorder Market by Country
    • 10.1.5.5 North America Central Nervous System Disorder Market by Country
    • 10.1.5.6 North America Others Market by Country
  • 10.1.6 North America Transdermal Patches Market by Country
    • 10.1.6.1 US Transdermal Patches Market
      • 10.1.6.1.1 US Transdermal Patches Market by End User
      • 10.1.6.1.2 US Transdermal Patches Market by Distribution Channel
      • 10.1.6.1.3 US Transdermal Patches Market by Adhesive Type
      • 10.1.6.1.4 US Transdermal Patches Market by Patch Type
      • 10.1.6.1.5 US Transdermal Patches Market by Application
    • 10.1.6.2 Canada Transdermal Patches Market
      • 10.1.6.2.1 Canada Transdermal Patches Market by End User
      • 10.1.6.2.2 Canada Transdermal Patches Market by Distribution Channel
      • 10.1.6.2.3 Canada Transdermal Patches Market by Adhesive Type
      • 10.1.6.2.4 Canada Transdermal Patches Market by Patch Type
      • 10.1.6.2.5 Canada Transdermal Patches Market by Application
    • 10.1.6.3 Mexico Transdermal Patches Market
      • 10.1.6.3.1 Mexico Transdermal Patches Market by End User
      • 10.1.6.3.2 Mexico Transdermal Patches Market by Distribution Channel
      • 10.1.6.3.3 Mexico Transdermal Patches Market by Adhesive Type
      • 10.1.6.3.4 Mexico Transdermal Patches Market by Patch Type
      • 10.1.6.3.5 Mexico Transdermal Patches Market by Application
    • 10.1.6.4 Rest of North America Transdermal Patches Market
      • 10.1.6.4.1 Rest of North America Transdermal Patches Market by End User
      • 10.1.6.4.2 Rest of North America Transdermal Patches Market by Distribution Channel
      • 10.1.6.4.3 Rest of North America Transdermal Patches Market by Adhesive Type
      • 10.1.6.4.4 Rest of North America Transdermal Patches Market by Patch Type
      • 10.1.6.4.5 Rest of North America Transdermal Patches Market by Application
• 10.2 Europe Transdermal Patches Market
  • 10.2.1 Europe Transdermal Patches Market by End User
    • 10.2.1.1 Europe Homecare Settings Market by Country
    • 10.2.1.2 Europe Hospitals & Clinics Market by Country
  • 10.2.2 Europe Transdermal Patches Market by Distribution Channel
    • 10.2.2.1 Europe Hospital Pharmacies Market by Country
    • 10.2.2.2 Europe Retail Pharmacies Market by Country
    • 10.2.2.3 Europe Online Pharmacies Market by Country
  • 10.2.3 Europe Transdermal Patches Market by Adhesive Type
    • 10.2.3.1 Europe Acrylic Adhesives Market by Country
    • 10.2.3.2 Europe Silicone Adhesives Market by Country
    • 10.2.3.3 Europe Hydrogel Adhesives Market by Country
    • 10.2.3.4 Europe Others Market by Country
  • 10.2.4 Europe Transdermal Patches Market by Patch Type
    • 10.2.4.1 Europe Drug-In-Adhesive Market by Country
    • 10.2.4.2 Europe Matrix Patches Market by Country
    • 10.2.4.3 Europe Reservoir Membrane Patches Market by Country
    • 10.2.4.4 Europe Microneedle Patches Market by Country
    • 10.2.4.5 Europe Iontophoresis Patches Market by Country
    • 10.2.4.6 Europe Vapour Patches Market by Country
  • 10.2.5 Europe Transdermal Patches Market by Application
    • 10.2.5.1 Europe Pain Management Market by Country
    • 10.2.5.2 Europe Smoking Cessation Market by Country
    • 10.2.5.3 Europe Hormone Replacement Therapy Market by Country
    • 10.2.5.4 Europe Cardiovascular Disorder Market by Country
    • 10.2.5.5 Europe Central Nervous System Disorder Market by Country
    • 10.2.5.6 Europe Others Market by Country
  • 10.2.6 Europe Transdermal Patches Market by Country
    • 10.2.6.1 Germany Transdermal Patches Market
      • 10.2.6.1.1 Germany Transdermal Patches Market by End User
      • 10.2.6.1.2 Germany Transdermal Patches Market by Distribution Channel
      • 10.2.6.1.3 Germany Transdermal Patches Market by Adhesive Type
      • 10.2.6.1.4 Germany Transdermal Patches Market by Patch Type
      • 10.2.6.1.5 Germany Transdermal Patches Market by Application
    • 10.2.6.2 UK Transdermal Patches Market
      • 10.2.6.2.1 UK Transdermal Patches Market by End User
      • 10.2.6.2.2 UK Transdermal Patches Market by Distribution Channel
      • 10.2.6.2.3 UK Transdermal Patches Market by Adhesive Type
      • 10.2.6.2.4 UK Transdermal Patches Market by Patch Type
      • 10.2.6.2.5 UK Transdermal Patches Market by Application
    • 10.2.6.3 France Transdermal Patches Market
      • 10.2.6.3.1 France Transdermal Patches Market by End User
      • 10.2.6.3.2 France Transdermal Patches Market by Distribution Channel
      • 10.2.6.3.3 France Transdermal Patches Market by Adhesive Type
      • 10.2.6.3.4 France Transdermal Patches Market by Patch Type
      • 10.2.6.3.5 France Transdermal Patches Market by Application
    • 10.2.6.4 Russia Transdermal Patches Market
      • 10.2.6.4.1 Russia Transdermal Patches Market by End User
      • 10.2.6.4.2 Russia Transdermal Patches Market by Distribution Channel
      • 10.2.6.4.3 Russia Transdermal Patches Market by Adhesive Type
      • 10.2.6.4.4 Russia Transdermal Patches Market by Patch Type
      • 10.2.6.4.5 Russia Transdermal Patches Market by Application
    • 10.2.6.5 Spain Transdermal Patches Market
      • 10.2.6.5.1 Spain Transdermal Patches Market by End User
      • 10.2.6.5.2 Spain Transdermal Patches Market by Distribution Channel
      • 10.2.6.5.3 Spain Transdermal Patches Market by Adhesive Type
      • 10.2.6.5.4 Spain Transdermal Patches Market by Patch Type
      • 10.2.6.5.5 Spain Transdermal Patches Market by Application
    • 10.2.6.6 Italy Transdermal Patches Market
      • 10.2.6.6.1 Italy Transdermal Patches Market by End User
      • 10.2.6.6.2 Italy Transdermal Patches Market by Distribution Channel
      • 10.2.6.6.3 Italy Transdermal Patches Market by Adhesive Type
      • 10.2.6.6.4 Italy Transdermal Patches Market by Patch Type
      • 10.2.6.6.5 Italy Transdermal Patches Market by Application
    • 10.2.6.7 Rest of Europe Transdermal Patches Market
      • 10.2.6.7.1 Rest of Europe Transdermal Patches Market by End User
      • 10.2.6.7.2 Rest of Europe Transdermal Patches Market by Distribution Channel
      • 10.2.6.7.3 Rest of Europe Transdermal Patches Market by Adhesive Type
      • 10.2.6.7.4 Rest of Europe Transdermal Patches Market by Patch Type
      • 10.2.6.7.5 Rest of Europe Transdermal Patches Market by Application
• 10.3 Asia Pacific Transdermal Patches Market
  • 10.3.1 Asia Pacific Transdermal Patches Market by End User
    • 10.3.1.1 Asia Pacific Homecare Settings Market by Country
    • 10.3.1.2 Asia Pacific Hospitals & Clinics Market by Country
  • 10.3.2 Asia Pacific Transdermal Patches Market by Distribution Channel
    • 10.3.2.1 Asia Pacific Hospital Pharmacies Market by Country
    • 10.3.2.2 Asia Pacific Retail Pharmacies Market by Country
    • 10.3.2.3 Asia Pacific Online Pharmacies Market by Country
  • 10.3.3 Asia Pacific Transdermal Patches Market by Adhesive Type
    • 10.3.3.1 Asia Pacific Acrylic Adhesives Market by Country
    • 10.3.3.2 Asia Pacific Silicone Adhesives Market by Country
    • 10.3.3.3 Asia Pacific Hydrogel Adhesives Market by Country
    • 10.3.3.4 Asia Pacific Others Market by Country
  • 10.3.4 Asia Pacific Transdermal Patches Market by Patch Type
    • 10.3.4.1 Asia Pacific Drug-In-Adhesive Market by Country
    • 10.3.4.2 Asia Pacific Matrix Patches Market by Country
    • 10.3.4.3 Asia Pacific Reservoir Membrane Patches Market by Country
    • 10.3.4.4 Asia Pacific Microneedle Patches Market by Country
    • 10.3.4.5 Asia Pacific Iontophoresis Patches Market by Country
    • 10.3.4.6 Asia Pacific Vapour Patches Market by Country
  • 10.3.5 Asia Pacific Transdermal Patches Market by Application
    • 10.3.5.1 Asia Pacific Pain Management Market by Country
    • 10.3.5.2 Asia Pacific Smoking Cessation Market by Country
    • 10.3.5.3 Asia Pacific Hormone Replacement Therapy Market by Country
    • 10.3.5.4 Asia Pacific Cardiovascular Disorder Market by Country
    • 10.3.5.5 Asia Pacific Central Nervous System Disorder Market by Country
    • 10.3.5.6 Asia Pacific Others Market by Country
  • 10.3.6 Asia Pacific Transdermal Patches Market by Country
    • 10.3.6.1 China Transdermal Patches Market
      • 10.3.6.1.1 China Transdermal Patches Market by End User
      • 10.3.6.1.2 China Transdermal Patches Market by Distribution Channel
      • 10.3.6.1.3 China Transdermal Patches Market by Adhesive Type
      • 10.3.6.1.4 China Transdermal Patches Market by Patch Type
      • 10.3.6.1.5 China Transdermal Patches Market by Application
    • 10.3.6.2 Japan Transdermal Patches Market
      • 10.3.6.2.1 Japan Transdermal Patches Market by End User
      • 10.3.6.2.2 Japan Transdermal Patches Market by Distribution Channel
      • 10.3.6.2.3 Japan Transdermal Patches Market by Adhesive Type
      • 10.3.6.2.4 Japan Transdermal Patches Market by Patch Type
      • 10.3.6.2.5 Japan Transdermal Patches Market by Application
    • 10.3.6.3 India Transdermal Patches Market
      • 10.3.6.3.1 India Transdermal Patches Market by End User
      • 10.3.6.3.2 India Transdermal Patches Market by Distribution Channel
      • 10.3.6.3.3 India Transdermal Patches Market by Adhesive Type
      • 10.3.6.3.4 India Transdermal Patches Market by Patch Type
      • 10.3.6.3.5 India Transdermal Patches Market by Application
    • 10.3.6.4 South Korea Transdermal Patches Market
      • 10.3.6.4.1 South Korea Transdermal Patches Market by End User
      • 10.3.6.4.2 South Korea Transdermal Patches Market by Distribution Channel
      • 10.3.6.4.3 South Korea Transdermal Patches Market by Adhesive Type
      • 10.3.6.4.4 South Korea Transdermal Patches Market by Patch Type
      • 10.3.6.4.5 South Korea Transdermal Patches Market by Application
    • 10.3.6.5 Singapore Transdermal Patches Market
      • 10.3.6.5.1 Singapore Transdermal Patches Market by End User
      • 10.3.6.5.2 Singapore Transdermal Patches Market by Distribution Channel
      • 10.3.6.5.3 Singapore Transdermal Patches Market by Adhesive Type
      • 10.3.6.5.4 Singapore Transdermal Patches Market by Patch Type
      • 10.3.6.5.5 Singapore Transdermal Patches Market by Application
    • 10.3.6.6 Malaysia Transdermal Patches Market
      • 10.3.6.6.1 Malaysia Transdermal Patches Market by End User
      • 10.3.6.6.2 Malaysia Transdermal Patches Market by Distribution Channel
      • 10.3.6.6.3 Malaysia Transdermal Patches Market by Adhesive Type
      • 10.3.6.6.4 Malaysia Transdermal Patches Market by Patch Type
      • 10.3.6.6.5 Malaysia Transdermal Patches Market by Application
    • 10.3.6.7 Rest of Asia Pacific Transdermal Patches Market
      • 10.3.6.7.1 Rest of Asia Pacific Transdermal Patches Market by End User
      • 10.3.6.7.2 Rest of Asia Pacific Transdermal Patches Market by Distribution Channel
      • 10.3.6.7.3 Rest of Asia Pacific Transdermal Patches Market by Adhesive Type
      • 10.3.6.7.4 Rest of Asia Pacific Transdermal Patches Market by Patch Type
      • 10.3.6.7.5 Rest of Asia Pacific Transdermal Patches Market by Application
• 10.4 LAMEA Transdermal Patches Market
  • 10.4.1 LAMEA Transdermal Patches Market by End User
    • 10.4.1.1 LAMEA Homecare Settings Market by Country
    • 10.4.1.2 LAMEA Hospitals & Clinics Market by Country
  • 10.4.2 LAMEA Transdermal Patches Market by Distribution Channel
    • 10.4.2.1 LAMEA Hospital Pharmacies Market by Country
    • 10.4.2.2 LAMEA Retail Pharmacies Market by Country
    • 10.4.2.3 LAMEA Online Pharmacies Market by Country
  • 10.4.3 LAMEA Transdermal Patches Market by Adhesive Type
    • 10.4.3.1 LAMEA Acrylic Adhesives Market by Country
    • 10.4.3.2 LAMEA Silicone Adhesives Market by Country
    • 10.4.3.3 LAMEA Hydrogel Adhesives Market by Country
    • 10.4.3.4 LAMEA Others Market by Country
  • 10.4.4 LAMEA Transdermal Patches Market by Patch Type
    • 10.4.4.1 LAMEA Drug-In-Adhesive Market by Country
    • 10.4.4.2 LAMEA Matrix Patches Market by Country
    • 10.4.4.3 LAMEA Reservoir Membrane Patches Market by Country
    • 10.4.4.4 LAMEA Microneedle Patches Market by Country
    • 10.4.4.5 LAMEA Iontophoresis Patches Market by Country
    • 10.4.4.6 LAMEA Vapour Patches Market by Country
  • 10.4.5 LAMEA Transdermal Patches Market by Application
    • 10.4.5.1 LAMEA Pain Management Market by Country
    • 10.4.5.2 LAMEA Smoking Cessation Market by Country
    • 10.4.5.3 LAMEA Hormone Replacement Therapy Market by Country
    • 10.4.5.4 LAMEA Cardiovascular Disorder Market by Country
    • 10.4.5.5 LAMEA Central Nervous System Disorder Market by Country
    • 10.4.5.6 LAMEA Others Market by Country
  • 10.4.6 LAMEA Transdermal Patches Market by Country
    • 10.4.6.1 Brazil Transdermal Patches Market
      • 10.4.6.1.1 Brazil Transdermal Patches Market by End User
      • 10.4.6.1.2 Brazil Transdermal Patches Market by Distribution Channel
      • 10.4.6.1.3 Brazil Transdermal Patches Market by Adhesive Type
      • 10.4.6.1.4 Brazil Transdermal Patches Market by Patch Type
      • 10.4.6.1.5 Brazil Transdermal Patches Market by Application
    • 10.4.6.2 Argentina Transdermal Patches Market
      • 10.4.6.2.1 Argentina Transdermal Patches Market by End User
      • 10.4.6.2.2 Argentina Transdermal Patches Market by Distribution Channel
      • 10.4.6.2.3 Argentina Transdermal Patches Market by Adhesive Type
      • 10.4.6.2.4 Argentina Transdermal Patches Market by Patch Type
      • 10.4.6.2.5 Argentina Transdermal Patches Market by Application
    • 10.4.6.3 UAE Transdermal Patches Market
      • 10.4.6.3.1 UAE Transdermal Patches Market by End User
      • 10.4.6.3.2 UAE Transdermal Patches Market by Distribution Channel
      • 10.4.6.3.3 UAE Transdermal Patches Market by Adhesive Type
      • 10.4.6.3.4 UAE Transdermal Patches Market by Patch Type
      • 10.4.6.3.5 UAE Transdermal Patches Market by Application
    • 10.4.6.4 Saudi Arabia Transdermal Patches Market
      • 10.4.6.4.1 Saudi Arabia Transdermal Patches Market by End User
      • 10.4.6.4.2 Saudi Arabia Transdermal Patches Market by Distribution Channel
      • 10.4.6.4.3 Saudi Arabia Transdermal Patches Market by Adhesive Type
      • 10.4.6.4.4 Saudi Arabia Transdermal Patches Market by Patch Type
      • 10.4.6.4.5 Saudi Arabia Transdermal Patches Market by Application
    • 10.4.6.5 South Africa Transdermal Patches Market
      • 10.4.6.5.1 South Africa Transdermal Patches Market by End User
      • 10.4.6.5.2 South Africa Transdermal Patches Market by Distribution Channel
      • 10.4.6.5.3 South Africa Transdermal Patches Market by Adhesive Type
      • 10.4.6.5.4 South Africa Transdermal Patches Market by Patch Type
      • 10.4.6.5.5 South Africa Transdermal Patches Market by Application
    • 10.4.6.6 Nigeria Transdermal Patches Market
      • 10.4.6.6.1 Nigeria Transdermal Patches Market by End User
      • 10.4.6.6.2 Nigeria Transdermal Patches Market by Distribution Channel
      • 10.4.6.6.3 Nigeria Transdermal Patches Market by Adhesive Type
      • 10.4.6.6.4 Nigeria Transdermal Patches Market by Patch Type
      • 10.4.6.6.5 Nigeria Transdermal Patches Market by Application
    • 10.4.6.7 Rest of LAMEA Transdermal Patches Market
      • 10.4.6.7.1 Rest of LAMEA Transdermal Patches Market by End User
      • 10.4.6.7.2 Rest of LAMEA Transdermal Patches Market by Distribution Channel
      • 10.4.6.7.3 Rest of LAMEA Transdermal Patches Market by Adhesive Type
      • 10.4.6.7.4 Rest of LAMEA Transdermal Patches Market by Patch Type
      • 10.4.6.7.5 est of LAMEA Transdermal Patches Market by Application

Chapter 11. Company Profiles

• 11.1 Johnson & Johnson
  • 11.1.1 Company Overview
  • 11.1.2 Financial Analysis
  • 11.1.3 Segmental and Regional Analysis
  • 11.1.4 Research & Development Expenses
  • 11.1.5 SWOT Analysis
• 11.2 Viatris, Inc. (Mylan N.V.)
  • 11.2.1 Company Overview
  • 11.2.2 Financial Analysis
  • 11.2.3 Segmental Analysis
  • 11.2.4 Research & Development Expense
  • 11.2.5 Recent strategies and developments:
    • 11.2.5.1 Partnerships, Collaborations, and Agreements:
  • 11.2.6 SWOT Analysis
• 11.3 Boehringer Ingelheim International GmbH
  • 11.3.1 Company Overview
  • 11.3.2 Financial Analysis
  • 11.3.3 Regional & Segmental Analysis
  • 11.3.4 Research & Development Expenses
  • 11.3.5 SWOT Analysis
• 11.4 Endo International PLC
  • 11.4.1 Company Overview
  • 11.4.2 Financial Analysis
  • 11.4.3 Segmental Analysis
  • 11.4.4 Research & Development Expense
  • 11.4.5 SWOT Analysis
• 11.5 Bayer AG
  • 11.5.1 Company Overview
  • 11.5.2 Financial Analysis
  • 11.5.3 Segmental and Regional Analysis
  • 11.5.4 Research & Development Expense
  • 11.5.5 SWOT Analysis
• 11.6 Nitto Denko Corporation
  • 11.6.1 Company Overview
  • 11.6.2 Financial Analysis
  • 11.6.3 Segmental Analysis
  • 11.6.4 Research & Development Expense
  • 11.6.5 SWOT Analysis
• 11.7 Cipla Limited
  • 11.7.1 Company Overview
  • 11.7.2 Financial Analysis
  • 11.7.3 Segmental and Regional Analysis
  • 11.7.4 Research & Development Expense
  • 11.7.5 Recent strategies and developments:
    • 11.7.5.1 Acquisition and Mergers:
  • 11.7.6 SWOT Analysis
• 11.8 Amneal Pharmaceuticals, Inc.
  • 11.8.1 Company Overview
  • 11.8.2 Financial Analysis
  • 11.8.3 Segmental Analysis
  • 11.8.4 Research & Development Expenses
  • 11.8.5 Recent strategies and developments:
    • 11.8.5.1 Product Launches and Product Expansions:
  • 11.8.6 SWOT Analysis
• 11.9 Novartis AG
  • 11.9.1 Company Overview
  • 11.9.2 Financial Analysis
  • 11.9.3 Segmental and Regional Analysis
  • 11.9.4 Research & Development Expense
  • 11.9.5 SWOT Analysis
• 11.10. AbbVie, Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Financial Analysis
  • 11.10.3 Regional Analysis
  • 11.10.4 Research & Development Expense
  • 11.10.5 SWOT Analysis

Chapter 12. Winning Imperatives of Transdermal Patches Market